Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KEAP1 |
Variant | D236H |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | KEAP1 D236H lies within the BACK domain of the Keap1 protein (UniProt.org). D236H confers a loss of function to the Keap1 protein as demonstrated by loss of Nfe2l2 inhibition leading to nuclear localization of Nfe2l2 in culture (PMID: 17020408), and is associated increased proliferation and migration in culture, tumor growth in animal models, and acquired resistance to tyrosine kinase inhibitors (PMID: 29812969). |
Associated Drug Resistance | Y |
Category Variants Paths |
KEAP1 mutant KEAP1 inact mut KEAP1 D236H |
Transcript | NM_203500.2 |
gDNA | chr19:g.10492196C>G |
cDNA | c.706G>C |
Protein | p.D236H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_203500 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
NM_012289.4 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
NM_012289.3 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_005260174.1 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
NM_203500.2 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_005260173.1 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_011528452 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_011528452.1 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_005260173 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
XM_005260174 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
NM_012289 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
NM_203500.1 | chr19:g.10492196C>G | c.706G>C | p.D236H | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|